1-1 of 1
Authors: Athene Hoi-Ying Lam
Journal Article
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e216–e226, https://doi.org/10.1093/cid/ciac523
Published: 29 July 2022
